Page last updated: 2024-08-21

fluorobenzenes and Hyperlipoproteinemia Type IV

fluorobenzenes has been researched along with Hyperlipoproteinemia Type IV in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anzenbacher, P; Anzenbacherová, E; Matuskova, Z; Siller, M; Skottová, N; Vecera, R; Zacharová, A1

Other Studies

1 other study(ies) available for fluorobenzenes and Hyperlipoproteinemia Type IV

ArticleYear
The influence of rosuvastatin on liver microsomal CYP2C6 in hereditary hypertriglyceridemic rat.
    Neuro endocrinology letters, 2012, Volume: 33 Suppl 3

    Topics: Animals; Aryl Hydrocarbon Hydroxylases; Cholesterol, Dietary; Cytochrome P-450 CYP2C9; Cytochrome P450 Family 2; Fluorobenzenes; Gene Expression Regulation, Enzymologic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type IV; Male; Microsomes, Liver; Pyrimidines; Rats; Rats, Mutant Strains; Rats, Wistar; RNA, Messenger; Rosuvastatin Calcium; Steroid 21-Hydroxylase; Sulfonamides; Transcription, Genetic

2012